List of works - Jolanta Krajewska

131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumors - a single center study

scientific article published on 12 April 2018

131I-MIBG therapy in the treatment of pheochromocytoma in children--own experiences

scientific article published in May 2008

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

scientific article published in May 2022

A registry-based study of thyroid paraganglioma: histological and genetic characteristics

scientific article published on 16 January 2015

A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas.

scientific article

Advances in small molecule therapy for treating metastatic thyroid cancer.

scientific article

Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.

scientific article published in January 2017

An internist's approach to cancer diseases based on the model of thyroid cancer treated with tyrosine kinase inhibitors.

scientific article

BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma

scientific article published in December 2015

Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer

scientific article

Childhood thyroid carcinoma — single-centre experience

scientific article published on 30 December 2021

Coexistence of Promoter Mutations and the V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients

scientific article published on 06 September 2018

Concentrations of Selected Adipokines, Interleukin-6, and Vitamin D in Patients with Papillary Thyroid Carcinoma in Respect to Thyroid Cancer Stages

scientific article published on 03 December 2018

Corrigendum: Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations

scientific article published on 15 March 2017

Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses? ⬇️

scientific article

Current status of the prognostic molecular markers in medullary thyroid carcinoma

scientific article published on 01 October 2020

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide

scientific article published on 30 June 2017

Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Tow

scientific article published on 27 April 2022

Diagnostics and Treatment of Thyroid Carcinoma

scientific article

Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of Polish National Societies.

scientific article

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist? ⬇️

scientific article published on 29 June 2020

Differences in Gene-Gene Interactions in Graves' Disease Patients Stratified by Age of Onset.

scientific article

Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.

scientific article published on 09 February 2017

Drug safety evaluation of lenvatinib for thyroid cancer.

scientific article

Dynamic risk stratification in the follow-up of thyroid cancer

scientific article

Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival

scientific article published on 06 October 2020

Efficacy of lenvatinib in treating thyroid cancer.

scientific article published on 11 July 2016

Emerging multikinase inhibitors for the treatment of differentiated thyroid cancer: whom to treat?

scientific article published in December 2016

European perspective on the use of molecular tests in the diagnosis and therapy of thyroid neoplasms

scientific article published on 01 February 2020

Fosbretabulin tromethamine in the treatment of thyroid cancer

scientific article published on 4 April 2016

Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours

scientific article

Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas

scientific article

Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update

scientific article published in January 2018

HLA Status in Patients with Chronic Spontaneous Urticaria

scientific article published on 18 June 2010

Heterogeneity of Thyroid Cancer

scientific article published on 6 February 2018

Impact of the Tumor Microenvironment on the Gene Expression Profile in Papillary Thyroid Cancer

scientific article published on 22 April 2020

Important considerations when choosing pharmacotherapy for Graves' disease in children.

scientific article

Lenvatinib for the treatment of radioiodine-refractory follicular and papillary thyroid cancer

scientific article published on 23 September 2014

Managing tyrosine kinase inhibitors side effects in thyroid cancer

scientific article published on 08 March 2017

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015.

scientific article published on 10 October 2017

Molecular classification of pituitary adenomas: in search for criteria useful for high-throughput studies

scientific article published on 17 February 2016

Multikinase Inhibitors for the Treatment of Progressive, Metastatic Medullary Thyroid Cancer - An Evolving Paradigm

scientific article published on 28 August 2014

Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study

scientific article published on 16 January 2019

Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma

scientific article published on 18 February 2019

Novel therapies for thyroid cancer

scientific article

Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.

scientific article published in January 2016

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

scientific article published on 05 September 2019

Radioactive iodine (RAI) treatment of hyperthyroidism is safe in patients with Graves' orbitopathy--a prospective study

scientific article published on 01 January 2014

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

scientific article

Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy

scientific article

Recent advances in precision medicine for the treatment of medullary thyroid cancer

scientific article published on 17 August 2021

Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer

scientific article published on 30 September 2015

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer

scientific article published on 01 February 2019

Somatic mutation profiling of follicular thyroid cancer by next generation sequencing

scientific article published on 6 June 2016

Sorafenib for the treatment of thyroid cancer: an updated review.

scientific article

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma

scientific article published on 17 June 2020

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors

scientific article published on 15 July 2015

The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience

scientific article published on 5 April 2013

The prevalence of somatic RAS mutations in medullary thyroid cancer - a Polish population study

scientific article published on January 2015

The role of FDG-PET in localization of recurrent lesions of differentiated thyroid cancer (DTC) in patients with asymptomatic hyperthyroglobulinemia in a real clinical practice

scientific article published on 10 August 2016

The role of postoperative adjuvant radiotherapy in the local control in medullary thyroid carcinoma

scientific article published on 01 November 2019

Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015

scientific article published in 2021

Thyroid diseases in pregnancy: guidelines of the Polish Society of Endocrinology [Choroby tarczycy w ciąży: zalecenia postępowania Polskiego Towarzystwa Endokrynologicznego]

scientific article published on 29 October 2021

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomes

scientific article published in 2022

Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.

scientific article published on June 2007

Unsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression profiling

scientific article published on 01 January 2013

[Completion total thyroidectomy in children with differentiated thyroid cancer]

scientific article published on 01 July 2006

[Diagnosis and treatment of thyroid cancer - Polish guidelines].

scientific article

[Indications for surgery of thyroid cancer based on bioptate molecular examination].

scientific article

[Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi]

scientific article published on 01 July 2006

[Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences]

scientific article published on 01 July 2006

List of works by Jolanta Krajewska

131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumors - a single center study

131I-MIBG therapy in the treatment of pheochromocytoma in children--own experiences

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

A registry-based study of thyroid paraganglioma: histological and genetic characteristics

A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas.

Advances in small molecule therapy for treating metastatic thyroid cancer.

Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.

An internist's approach to cancer diseases based on the model of thyroid cancer treated with tyrosine kinase inhibitors.

BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma

Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer

Childhood thyroid carcinoma — single-centre experience

Coexistence of Promoter Mutations and the V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients

Concentrations of Selected Adipokines, Interleukin-6, and Vitamin D in Patients with Papillary Thyroid Carcinoma in Respect to Thyroid Cancer Stages

Corrigendum: Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations

Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses? ⬇️

Current status of the prognostic molecular markers in medullary thyroid carcinoma

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide

Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Tow

Diagnostics and Treatment of Thyroid Carcinoma

Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of Polish National Societies.

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist? ⬇️

Differences in Gene-Gene Interactions in Graves' Disease Patients Stratified by Age of Onset.

Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.

Drug safety evaluation of lenvatinib for thyroid cancer.

Dynamic risk stratification in the follow-up of thyroid cancer

Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival

Efficacy of lenvatinib in treating thyroid cancer.

Emerging multikinase inhibitors for the treatment of differentiated thyroid cancer: whom to treat?

European perspective on the use of molecular tests in the diagnosis and therapy of thyroid neoplasms

Fosbretabulin tromethamine in the treatment of thyroid cancer

Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours

Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas

Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update

HLA Status in Patients with Chronic Spontaneous Urticaria

Heterogeneity of Thyroid Cancer

Impact of the Tumor Microenvironment on the Gene Expression Profile in Papillary Thyroid Cancer

Important considerations when choosing pharmacotherapy for Graves' disease in children.

Lenvatinib for the treatment of radioiodine-refractory follicular and papillary thyroid cancer

Managing tyrosine kinase inhibitors side effects in thyroid cancer

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015.

Molecular classification of pituitary adenomas: in search for criteria useful for high-throughput studies

Multikinase Inhibitors for the Treatment of Progressive, Metastatic Medullary Thyroid Cancer - An Evolving Paradigm

Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study

Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma

Novel therapies for thyroid cancer

Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

Radioactive iodine (RAI) treatment of hyperthyroidism is safe in patients with Graves' orbitopathy--a prospective study

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy

Recent advances in precision medicine for the treatment of medullary thyroid cancer

Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer

Somatic mutation profiling of follicular thyroid cancer by next generation sequencing

Sorafenib for the treatment of thyroid cancer: an updated review.

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors

The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience

The prevalence of somatic RAS mutations in medullary thyroid cancer - a Polish population study

The role of FDG-PET in localization of recurrent lesions of differentiated thyroid cancer (DTC) in patients with asymptomatic hyperthyroglobulinemia in a real clinical practice

The role of postoperative adjuvant radiotherapy in the local control in medullary thyroid carcinoma

Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015

Thyroid diseases in pregnancy: guidelines of the Polish Society of Endocrinology [Choroby tarczycy w ciąży: zalecenia postępowania Polskiego Towarzystwa Endokrynologicznego]

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomes

Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.

Unsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression profiling

[Completion total thyroidectomy in children with differentiated thyroid cancer]

[Diagnosis and treatment of thyroid cancer - Polish guidelines].

[Indications for surgery of thyroid cancer based on bioptate molecular examination].

[Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi]

[Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences]